Liying Gong

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Left Ventricular

Acute Coronary Syndrome

Patient Reported

Binding Protein

Top Venues

Drug design, development and therapy

Clinical cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Chenxi Ouyang, Changjiang Meng, Fei Li, Shanshan Nie, Liying Gong, Yu Cao, Hong Yuan, Ze-Ying Feng
Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence. Drug design, development and therapy 18 (2024)
Chenxi Ouyang, Changjiang Meng, Fei Li, Shanshan Nie, Liying Gong, Yu Cao, Hong Yuan, Ze-Ying Feng
Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence. Drug design, development and therapy 18 (2024)
Chenxi Ouyang, Changjiang Meng, Fei Li, Shanshan Nie, Liying Gong, Yu Cao, Hong Yuan, Ze-Ying Feng
Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence. Drug design, development and therapy 18 (2024)
Long Song, Yuan Li, Shanshan Nie, Zeying Feng, Yaxin Liu, Fangfang Ding, Liying Gong, Liming Liu, Guo-Ping Yang
Using machine learning to predict adverse events in acute coronary syndrome: A retrospective study. Clinical cardiology (2023)